Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

ABSTRACT: The purpose of this study is to determine confirmed objective response rate to combination therapy with cetuximab plus XELOX for 4 cycles followed by maintenance treatment with cetuximab plus capecitabine as first line treatment in elderly patients with metastatic colorectal cancer

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms,Pacientes Ancianos Con Cáncer Colorrectal Metastásico

PROVIDER: 2044336 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR